Literature DB >> 22067398

Path toward prognostication and prediction: an evolving matrix.

Al B Benson, Stanley R Hamilton.   

Abstract

Mesh:

Year:  2011        PMID: 22067398     DOI: 10.1200/JCO.2011.37.8646

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

Authors:  Donna Niedzwiecki; Wendy L Frankel; Alan P Venook; Xing Ye; Paula N Friedman; Richard M Goldberg; Robert J Mayer; Thomas Anthony Colacchio; Jude Marie Mulligan; Timothy S Davison; Eamonn O'Brien; Peter Kerr; Patrick G Johnston; Richard D Kennedy; D Paul Harkin; Richard L Schilsky; Monica M Bertagnolli; Robert S Warren; Federico Innocenti
Journal:  J Clin Oncol       Date:  2016-07-18       Impact factor: 44.544

3.  Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

Authors:  Anthony C Wong; Shannon Stock; Deborah Schrag; Katherine L Kahn; Talya Salz; Mary E Charlton; Selwyn O Rogers; Karyn A Goodman; Nancy L Keating
Journal:  J Oncol Pract       Date:  2014-07-01       Impact factor: 3.840

4.  High Expression of DARPP-32 in Colorectal Cancer Is Associated With Liver Metastases and Predicts Survival for Dukes A and B Patients: Results of a Pilot Study.

Authors:  Mario Kopljar; Leonardo Patrlj; Dragan Korolija-Marinic; Matija Horzic; Kristijan Cupurdija; Bore Bakota
Journal:  Int Surg       Date:  2015-02

5.  Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.

Authors:  Simon Lavotshkin; John R Jalas; Hitoe Torisu-Itakura; Junko Ozao-Choy; Ji Hey Lee; Myung Shin Sim; Alexander Stojadinovic; Zev Wainberg; Carlo B Bifulco; Bernard A Fox; Anton J Bilchik
Journal:  J Gastrointest Surg       Date:  2015-03-26       Impact factor: 3.452

6.  Extent of enhancement on multiphase contrast-enhanced CT images is a potential prognostic factor of stage I-III colon cancer.

Authors:  Zhanhuai Wang; Yao Ye; Yeting Hu; Shugao Han; Lifeng Sun; Dong Xu; Kefeng Ding
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

7.  Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Authors:  Bernhard Mlecnik; Carlo Bifulco; Gabriela Bindea; Florence Marliot; Alessandro Lugli; J Jack Lee; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Lucie Lafontaine; Daniela Bruni; Anastasia Lanzi; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Christopher Paustian; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Muşină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Bernard A Fox; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2020-09-08       Impact factor: 44.544

8.  Clinical Significance and Inflammatory Landscape of aNovel Recurrence-Associated Immune Signature in Stage II/III Colorectal Cancer.

Authors:  Zaoqu Liu; Taoyuan Lu; Jing Li; Libo Wang; Kaihao Xu; Qin Dang; Long Liu; Chunguang Guo; Dechao Jiao; Zhenqiang Sun; Xinwei Han
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

9.  Nomograms to predict survival after colorectal cancer resection without preoperative therapy.

Authors:  Zhen-Yu Zhang; Qi-Feng Luo; Xiao-Wei Yin; Zhen-Ling Dai; Shiva Basnet; Hai-Yan Ge
Journal:  BMC Cancer       Date:  2016-08-19       Impact factor: 4.430

10.  Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer.

Authors:  Zaoqu Liu; Taoyuan Lu; Jing Li; Libo Wang; Kaihao Xu; Qin Dang; Chunguang Guo; Long Liu; Dechao Jiao; Zhenqiang Sun; Xinwei Han
Journal:  Cancer Cell Int       Date:  2021-07-07       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.